Keywords: Patent filings, Biologicals, Small-molecule drugs, Withers & Rogers, Novartis, Abbott, GlaxoSmithKline, Sanofi, AstraZeneca, Pfizer

Gap in patent filings for biological and small-molecule drugs widening, says Withers & Rogers

Article | 20 March 2012

Print This

The number of patent applications filed by leading pharmaceutical companies for biological drugs has exceeded those for small molecules for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in